Zusammenfassung
Die auditorische Synaptopathie/Neuropathie (AS/AN) stellt eine in ihrer Häufigkeit unterschätzte Form der sensorineuralen Schwerhörigkeit mit sehr heterogener klinischer Ausprägung dar. Bei vielen Betroffenen besteht die Hörstörung seit Geburt, bei einigen erst im Erwachsenenalter. Symptome sind der schwankende, meist beidseitig auftretende Hörverlust und die oft starke Einschränkung des Sprachverstehens, insbesondere im Störgeräusch. Otoakustische Emissionen (OAE) und cochleäre Mikrofonpotenziale (CM) lassen sich nachweisen, Stapediusreflexe fehlen und frühe akustisch evozierte Potenziale (FAEP) sind nicht nachweisbar oder stark verändert. Durch ein rein OAE-basiertes Neugeborenen-Hörscreening werden Kinder mit AS/AN nicht erkannt. Klinische Befunde, transtympanale Elektrocochleographie (ECochG) und weiterführende Diagnostik lassen die individuelle Ausprägung der AS/AN erkennen. Im Einzelfall können der Einsatz von Hörgeräten und/oder FM-Anlagen die Hör- und Kommunikationsfähigkeit verbessern. Sind diese Maßnahmen in Verbindung mit einer intensiven Hör-, Sprech- und Sprachfrühförderung unzureichend, stellen die CI-Versorgung oder der Einsatz alternativer Kommunikationsformen sinnvolle Optionen dar.
Abstract
Auditory synaptopathy/neuropathy (AS/AN) is a special subtype of sensorineural hearing disorders with heterogenous phenotypes and underestimated incidence. AS/AN generally develops in infancy, occasionally in adulthood. Symptoms include fluctuating, mostly bilateral hearing loss and abnormally reduced speech comprehension, especially in noisy environments. Within audiological assessments, patients with AS/AN present otoacoustic emissions (TEOAE; DPOAE) and cochlear microphonics (CM), absence of stapedius reflexes (SR) as well as absent or pathologically altered auditory evoked brainstem potentials (ABR). Children with AS/AN cannot be identified within OAE-based newborn hearing screening programs. Clinical findings, transtympanic electrocochleography (ECoG) and further diagnostic tools permit further identification of individual characteristics. In individual cases conventional amplification and the use of FM systems may improve hearing and communication skills. If these interventions, accompanied by intensive hearing, speech and language therapy are unsuccessful, cochlear implants (CI) or alternative forms of communication may be useful options for rehabilitation.
Literatur
Beutner D, Foerst A, Lang-Roth R et al (2007) Risk factors for auditory neuropathy/auditory synaptopathy. ORL 69:239–244
Butinar D, Zidar J, Leonardis L et al (1999) Hereditary auditory, vestibular, motor, and sensory neuropathy in a Slovenian Roma (Gipsy) kindred. Ann Neurol 46:36–44
Davis H, Hirsh SK (1979) A slow brain stem response for low-frequency audiometry. Audiology 18:445–461
Foerst A, Beutner D, Lang-Roth R et al (2006) Prevalence of auditory neuropathy/synaptopathy in a population of children with profound hearing loss. Int J Pediatr Otorhinolaryngology 70(8):1415–1422
Gibson WPR, Sanli H (2007) Auditory neuropathy: an update. Ear Hear 28(2 Suppl):102S–105S
Hallpike CS, Harriman DG, Wells CE (1980) A case of afferent neuropathy and deafness. J Laryngol Otol 94:945–964
Hood L, Berlin CI, Bordelon J et al (2003) Patients with auditory neuropathy/dys-synchrony lack efferent suppression of transient evoked otoacoustic emissions. J Am Acad Audiol 14:302–313
Keilmann A, Rühl S, Lenarz T, Lesinski-Schiedat A (2005) Erfolg der Cochlea-Implantation bei perisynaptischer Audiopathie (auditorischer Neuropathie), ein matched-pairs-Vergleich. Z Audiol 44(1):10–18
Khimich D, Nouvian R, Pujol R et al (2005) Hair cell synaptic ribbons are essential for synchronous auditory signalling. Nature 434:889–894
Kraus N, Ozdamar O, Stein L et al (1984) Absent auditory brainstem response: peripheral hearing loss or brainstem dysfunction? Laryngoscope 94:400–406
Lesinski-Schiedat A, Frohne C, Hemmaoil I et al (2001) Funktionelle Taubheit bei perisynaptischer Audiopathie – Isolierte Störungen der inneren Haarzellen? Laryngorhinootologie 80:601–604
Madden C, Hilbert L, Rutter J et al (2002) Pediatric cochlear implantation in auditory neuropathy. Otol Neurotol 23:163–168
Manchaiah VKC, Zhao F, Danesh AA, Duprey R (2011) The genetic basis of auditory neuropathy spectrum disorders (ANSD). Int J Ped Otorhinolaryngol 75:151–158
McMahon CM, Patuzzi RB, Gibson WPR, Sanli H (2008) Frequency-specific electrocochleography indicates that presynaptic and postsynatic mechanisms of auditory neuropathy exist. Ear Hear 29(3):314–325
Moser T, Strenzke N, Meyer A et al (2006) Diagnosis and therapy of auditory synaptopathy/neuropathy. HNO 54(11):833–841
Ptok M (2000) Otoacoustic emissions, auditory evoked potentials, pure tone thresholds and speech intelligibility in cases of auditory neuropathy. HNO 48:28–32
Rance G, Beer DE, Cone-Wesson B et al (1999) Clinical findings for a group of infants and young children with auditory neuropathy. Ear Hear 20:238–252
Rance G, Cone-Wesson B, Wunderlich J, Dowell R (2002) Speech perception and cortical event related potentials in children with auditory neuropathy. Ear Hear 23:239–253
Rance G, McCay C, Grayden D (2004) Perceptual characterization of children with auditory neuropathy. Ear Hear 25:34–46
Rance G, Barker E, Mok M et al (2007) Speech perception in noise for children with auditory neuropathy/dys-synchrony type hearing loss. Ear Hear 28:351–360
Rapin I, Gravel JS (2006) Auditory neuropathy: a biologically inappropriate label unless acoustic nerve involvement is documented. J Am Acad Audiol 39:147–150
Starr A, Picton TW, Sininger Y et al (1996) Auditory neuropathy. Brain 119:741–753
Starr A, Sininger Y, Pratt H (2000) The varieties of auditory neuropathy. J Basic Clin Physiol Pharmacol 11:215–230
Starr A, Sininger Y, Nguyen T et al (2001) Cochlear receptor (microphonic and summating potentials, otoacoustic emissions) and auditory pathway (auditory brainstem potentials) activity in auditory neuropathy. Ear Hear 22:741–753
Starr A, Michalewski HJ, Zeng FG et al (2003) Pathology and physiology of auditory neuropathy with a novel mutation in the MPZ gene (Tyr145→Ser). Brain 126:1604–1619
Strenzke N, Pauli-Magnus D, Meyer A et al (2008) Update zur Physiologie und Pathophysiologie des Innenohres. HNO 56:27–36
Taegle HFB, Roush PA, Woodard JS et al (2010) Cochlear implantation in children with auditory neuropathy spectrum disorder. Ear Hear 31(3):325–335
Varga R, Kelley PM, Keats BJ et al (2003) Non-syndromic recessive auditory neuropathy is the result of mutations in the otoferlin (OTOF) gene. J Med Genet 40:45–50
Vlastarakos PV, Nikolopoulos TP, Tavoulari E et al (2008) Auditory neuropathy: Endocochlear lesion or temporal processing impairment? Implications for diagnosis and management. Int J Ped Otorhinolaryngol 72:1135–1150
Worthington DW, Peters J (1980) Quantifiable hearing and no ABR: paradox or error? Ear Hear 1:281–285
Yasunaga S, Grati M, Cohen-Salmon M et al (1999) A mutation in OTOF, encoding otoferlin, a FER-1-like protein, causes DFNB9, a non-syndromic form of deafness. Nat Genet 21:363–369
Interessenkonflikt
Der korrespondierende Autor gibt an, dass kein Interessenkonflikt besteht.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Walger, M., Foerst, A., Beutner, D. et al. Auditorische Synaptopathie/Neuropathie. HNO 59, 414–424 (2011). https://doi.org/10.1007/s00106-011-2301-4
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00106-011-2301-4